We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
Cap. Flow
-$59.5M
Cap. Flow %
-0.14%
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128

Sector Composition

Rank Sector Weight
1 Financials 16.4%
2 Technology 15.29%
3 Healthcare 13.69%
4 Industrials 10.84%
5 Consumer Discretionary 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRDN icon
2826
Viridian Therapeutics
VRDN
$2.16B
$156K ﹤0.01%
+805
New +$136K
HSTO
2827
DELISTED
Histogen Inc. Common Stock
HSTO
$156K ﹤0.01%
+136
New +$166K
AMPY icon
2828
Amplify Energy
AMPY
$157M
$155K ﹤0.01%
+12,260
New +$207K
RSYS
2829
DELISTED
Radisys Corp
RSYS
$155K ﹤0.01%
41,125
+8,575
+26% +$33.5K
SBBP
2830
DELISTED
Strongbridge Biopharma plc.
SBBP
$154K ﹤0.01%
+21,526
New +$99.5K
BCBP icon
2831
BCB Bancorp
BCBP
$179M
$153K ﹤0.01%
+10,008
New +$157K
TRAK icon
2832
ReposiTrak
TRAK
$159M
$153K ﹤0.01%
12,555
+415
+3% +$5.1K
NWHM
2833
DELISTED
THE NEW HOME COMPANY INC.
NWHM
$153K ﹤0.01%
13,305
+1,150
+9% +$12.8K
AP icon
2834
Ampco-Pittsburgh
AP
$168M
$152K ﹤0.01%
+10,286
New +$154K
AAC
2835
DELISTED
AAC Holdings
AAC
$151K ﹤0.01%
21,719
+6,040
+39% +$43.1K
CVRS
2836
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$150K ﹤0.01%
80,868
+32,608
+68% +$43.4K
SHLD
2837
DELISTED
Sears Holding Corporation
SHLD
$150K ﹤0.01%
16,965
+1,394
+9% +$13K
PLPM
2838
DELISTED
Planet Payment, Inc
PLPM
$150K ﹤0.01%
45,355
+4,280
+10% +$16.2K
NEOS
2839
DELISTED
Neos Therapeutics, Inc
NEOS
$149K ﹤0.01%
20,409
+2,441
+14% +$18.4K
TRVN
2840
DELISTED
Trevena, Inc.
TRVN
$148K ﹤0.01%
103
+24
+30% +$44.1K
FNM
2841
DELISTED
FANNIE MAE
FNM
$148K ﹤0.01%
63,500
HDNG
2842
DELISTED
Hardinge Inc
HDNG
$147K ﹤0.01%
+11,804
New +$136K
FRE
2843
DELISTED
FREDDIE MAC D/B/A VOTING
FRE
$147K ﹤0.01%
66,008
TLYS icon
2844
Tilly's
TLYS
$114M
$146K ﹤0.01%
14,358
+580
+4% +$5.52K
NVLN
2845
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$146K ﹤0.01%
+15,838
New +$153K
VYGR icon
2846
Voyager Therapeutics
VYGR
$186M
$144K ﹤0.01%
16,091
+4,144
+35% +$41.7K
ICD
2847
DELISTED
Independence Contract Drilling, Inc.
ICD
$143K ﹤0.01%
1,841
+346
+23% +$30.2K
CASC
2848
DELISTED
Cascadian Therapeutics, Inc.
CASC
$143K ﹤0.01%
+38,394
New +$152K
PMBC
2849
DELISTED
Pacific Mercantile Bancorp
PMBC
$141K ﹤0.01%
16,038
+3,960
+33% +$31.3K
ROX
2850
DELISTED
Castle Brands, Inc.
ROX
$141K ﹤0.01%
+82,130
New +$145K

Similar funds

RhumbLine Advisers's Q2 2017 Portfolio in Review

As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
  • RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
  • RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
  • RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
  • RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
  • RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.

Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.